Saturday 17 October 2026 Export GDTC’s income statement to Excel — free account

CytoMed Therapeutics Limited

CytoMed Therapeutics Limited’s revenue for fiscal 2025 (year ended December 2025) was $252,300.00, up 395.7% from fiscal 2024. Insiders bought in the last twelve months.

0.88 0.01 +1.15%

Follow GDTC

Alert me

Market cap: $10.3M
P/E: 0.0×
Fwd P/E: −13.6×
Dividend yield: —
F-score: n/a
Altman Z: 6.84
Beneish M: 0.11
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+7 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	—
Free Cash Flow Full definition →		(8.45)	(8.47)	(9.19)	—
Capital Expenditures Full definition →		(1.51)	(1.77)	(2.22)	—
Other line items
Cash ROIC Full definition →		(79.80%)	(102.09%)	(125.55%)	0.00%
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.00	0.00	0.00	—
Depreciation/Fixed assets Full definition →		0.22	0.29	0.18	0.00
Capex/Depreciation Full definition →		(1.87)	(2.22)	(2.71)	—
Operating CF per Share Full definition →		0.00	0.00	0.00	—
Capex per Share Full definition →		0.00	0.00	0.00	—
Capex to Sales Full definition →		0.00	0.00	0.00	—

Show all line items

Columns are period end dates · fundamentals updated 2 Oct 2026

Stockrow Weekly